← Back to All US Stocks

U S Physical Therapy Inc. /N.V. (USPH) Stock Fundamental Analysis & AI Rating 2026

USPH NYSE Services-Health Services NV CIK: 0000885978
Recently Updated • Analysis: Apr 18, 2026 • SEC Data: 2025-12-31
HOLD
72% Conf
Pending
Analysis scheduled

📊 USPH Key Takeaways

Revenue: $781.0M
Net Margin: 5.1%
Free Cash Flow: $61.0M
Current Ratio: 1.01x
Debt/Equity: 0.32x
EPS: $1.42
AI Rating: HOLD with 72% confidence
U S Physical Therapy Inc. /N.V. (USPH) receives a HOLD rating with 72% confidence from our AI fundamental analysis based on SEC 10-K filings. With revenue of $781.0M, net profit margin of 5.1%, and return on equity (ROE) of 8.3%, U S Physical Therapy Inc. /N.V. demonstrates mixed fundamentals in the Services sector. Below is our complete USPH stock analysis for 2026.

Is U S Physical Therapy Inc. /N.V. (USPH) a Good Investment?

Claude

USPH demonstrates operational efficiency with 26% net income growth and strong $61M free cash flow generation, supported by a conservative balance sheet (0.32x Debt/Equity, 41.7x interest coverage). However, flat revenue growth and concerning 22.8% EPS dilution indicate shareholder value is being destroyed despite profitability improvements, while a tight 1.01x current ratio raises liquidity concerns.

Why Buy U S Physical Therapy Inc. /N.V. Stock? USPH Key Strengths

Claude
  • + Exceptional free cash flow of $61M (7.8% FCF margin) demonstrates underlying operational strength despite revenue stagnation
  • + Fortress balance sheet with 0.32x Debt/Equity and 41.7x interest coverage ratio provides financial flexibility and safety
  • + Net margin expansion to 5.1% and operating margin of 11.1% show strong cost control and operational leverage despite flat top-line

USPH Stock Risks: U S Physical Therapy Inc. /N.V. Investment Risks

Claude
  • ! Revenue growth of 0% YoY indicates the company is in mature/stagnant phase with no organic expansion capability
  • ! Severe EPS dilution of 22.8% decline despite 26% net income growth signals massive shareholder dilution from equity issuance
  • ! Current ratio of 1.01x is dangerously tight and suggests liquidity stress despite strong cash generation

Key Metrics to Watch

Claude
  • * Revenue growth trajectory and organic vs. acquisition-driven growth breakdown
  • * Share count changes and reasons for significant equity dilution despite earnings growth
  • * Current ratio improvement and working capital management to assess liquidity adequacy

U S Physical Therapy Inc. /N.V. (USPH) Financial Metrics & Key Ratios

Revenue
$781.0M
Net Income
$39.6M
EPS (Diluted)
$1.42
Free Cash Flow
$61.0M
Total Assets
$1.2B
Cash Position
$35.6M

💡 AI Analyst Insight

U S Physical Therapy Inc. /N.V. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.

USPH Profit Margin, ROE & Profitability Analysis

Gross Margin 19.2%
Operating Margin 11.1%
Net Margin 5.1%
ROE 8.3%
ROA 3.3%
FCF Margin 7.8%

USPH vs Services Sector: How U S Physical Therapy Inc. /N.V. Compares

How U S Physical Therapy Inc. /N.V. compares to Services sector averages

Net Margin
USPH 5.1%
vs
Sector Avg 10.0%
USPH Sector
ROE
USPH 8.3%
vs
Sector Avg 16.0%
USPH Sector
Current Ratio
USPH 1.0x
vs
Sector Avg 1.5x
USPH Sector
Debt/Equity
USPH 0.3x
vs
Sector Avg 0.7x
USPH Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is U S Physical Therapy Inc. /N.V. Stock Overvalued? USPH Valuation Analysis 2026

Based on fundamental analysis, U S Physical Therapy Inc. /N.V. has mixed fundamental signals relative to the Services sector in 2026.

Return on Equity
8.3%
Sector avg: 16%
Net Profit Margin
5.1%
Sector avg: 10%
Revenue Growth
N/A
Year-over-year
Debt/Equity
0.32x
Sector avg: 0.7x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

U S Physical Therapy Inc. /N.V. Balance Sheet: USPH Debt, Cash & Liquidity

Current Ratio
1.01x
Quick Ratio
1.01x
Debt/Equity
0.32x
Debt/Assets
36.0%
Interest Coverage
41.69x
Long-term Debt
$152.6M

USPH Revenue & Earnings Growth: 5-Year Financial Trend

USPH 5-year financial data: Year 2021: Revenue $495.0M, Net Income $40.0M, EPS $2.45. Year 2022: Revenue $553.1M, Net Income $35.2M, EPS $2.48. Year 2023: Revenue $604.8M, Net Income $40.8M, EPS $2.41. Year 2024: Revenue $671.3M, Net Income $32.2M, EPS $2.25. Year 2025: Revenue $781.0M, Net Income $28.2M, EPS $1.28.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: U S Physical Therapy Inc. /N.V.'s revenue has grown significantly by 58% over the 5-year period, indicating strong business expansion. The most recent EPS of $1.28 reflects profitable operations.

USPH Revenue Growth, EPS Growth & YoY Performance

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
7.8%
Free cash flow / Revenue

USPH Quarterly Earnings & Performance

Quarterly financial performance data for U S Physical Therapy Inc. /N.V. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2025 $168.0M $6.6M $0.39
Q2 2025 $167.2M $7.5M $0.47
Q1 2025 $155.7M $8.0M $0.46
Q3 2024 $150.0M $6.6M $0.39
Q2 2024 $151.5M $7.5M $0.47
Q1 2024 $148.5M $7.4M $0.46
Q3 2023 $139.6M $9.3M $0.51
Q2 2023 $140.7M $10.9M $0.64

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

U S Physical Therapy Inc. /N.V. Dividends, Buybacks & Capital Allocation

Operating Cash Flow
$75.1M
Cash generated from operations
Stock Buybacks
$5.6M
Shares repurchased (TTM)
Capital Expenditures
$14.1M
Investment in assets
Dividends Paid
$27.4M
Returned to shareholders

USPH SEC Filings: Latest 10-K & 10-Q Analysis

Access official SEC EDGAR filings for U S Physical Therapy Inc. /N.V. (CIK: 0000885978)

📋 Recent SEC Filings

Date Form Document Action
Apr 16, 2026 DEF 14A ny20065561x1_def14a.htm View →
Apr 15, 2026 8-K form8-k.htm View →
Mar 13, 2026 8-K form8-k.htm View →
Mar 12, 2026 4 xslF345X05/ownership.xml View →
Mar 11, 2026 4 xslF345X05/ownership.xml View →

Frequently Asked Questions about USPH

What is the AI rating for USPH?

U S Physical Therapy Inc. /N.V. (USPH) has an AI rating of HOLD with 72% confidence, based on fundamental analysis of SEC EDGAR filings.

What are USPH's key strengths?

Claude: Exceptional free cash flow of $61M (7.8% FCF margin) demonstrates underlying operational strength despite revenue stagnation. Fortress balance sheet with 0.32x Debt/Equity and 41.7x interest coverage ratio provides financial flexibility and safety.

What are the risks of investing in USPH?

Claude: Revenue growth of 0% YoY indicates the company is in mature/stagnant phase with no organic expansion capability. Severe EPS dilution of 22.8% decline despite 26% net income growth signals massive shareholder dilution from equity issuance.

What is USPH's revenue and growth?

U S Physical Therapy Inc. /N.V. reported revenue of $781.0M.

Does USPH pay dividends?

U S Physical Therapy Inc. /N.V. pays dividends, with $27.4M distributed to shareholders in the trailing twelve months.

Where can I find USPH SEC filings?

Official SEC filings for U S Physical Therapy Inc. /N.V. (CIK: 0000885978) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is USPH's EPS?

U S Physical Therapy Inc. /N.V. has a diluted EPS of $1.42.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Is USPH a good stock to buy right now?

Based on our AI fundamental analysis in April 2026, U S Physical Therapy Inc. /N.V. has a HOLD rating with 72% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.

Is USPH stock overvalued or undervalued?

Valuation metrics for USPH: ROE of 8.3% (sector avg: 16%), net margin of 5.1% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.

Should I buy USPH stock in 2026?

Our dual AI analysis gives U S Physical Therapy Inc. /N.V. a combined HOLD rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is USPH's free cash flow?

U S Physical Therapy Inc. /N.V.'s operating cash flow is $75.1M, with capital expenditures of $14.1M. FCF margin is 7.8%.

How does USPH compare to other Services stocks?

Vs Services sector averages: Net margin 5.1% (avg: 10%), ROE 8.3% (avg: 16%), current ratio 1.01 (avg: 1.5).

Top Rated Stocks
NSSC 92% MLI 92% MELI 92% MDXG 92% MANH 92% INVA 92% GGG 92% GCT 92% FTNT 92% FSLR 92%
Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Apr 18, 2026 | Data as of: 2025-12-31 | Powered by Claude AI